Breast-cancer risk in families with mutations in PALB2: The authors reply

New England Journal of Medicine

Volumn 371, Issue 17, 2014, Pages 1651-1652

  Antoniou, Antonis C ^a   Foulkes, William D ^b   Tischkowitz, Marc ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; ETHNIC GROUP; FAMILIAL CANCER; FAMILY HISTORY; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; LETTER; MUTATIONAL ANALYSIS; PALB2 GENE; POPULATION GENETICS; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE; BREAST TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; GERMLINE MUTATION; NOTE;

NUCLEAR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

BREAST NEOPLASMS; FEMALE; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 84908145253     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1410673     Document Type: Letter

References (3)

1. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117- 30.
2. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302:643-6.
3. Lee AJ, Cunningham AP, Kuchenbaecker KB, Mavaddat N, Easton DF, Antoniou AC. BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface. Br J Cancer 2014;110:535-45.